The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ADVERUM BIOTECHNOLOGIES INC COM 00773U108   15,900,000 10,000,000 SH   SOLE   10,000,000 0 0
AEGLEA BIOTHERAPEUTICS INC COM 00773J103   1,310,099 2,908,100 SH   SOLE   2,908,100 0 0
AKERO THERAPEUTICS INC COM 00973Y108   78,205,750 1,675,000 SH   SOLE   1,675,000 0 0
ALPINE IMMUNE SCIENCES INC COM 02083G100   13,621,000 1,325,000 SH   SOLE   1,325,000 0 0
AMBRX BIOPHARMA INC SPONSORED ADS 02290A102   52,260,500 3,175,000 SH   SOLE   3,175,000 0 0
ARROWHEAD PHARMACEUTICALS IN COM 04280A100   21,752,600 610,000 SH   SOLE   610,000 0 0
CABALETTA BIO INC COM 12674W109   30,573,281 2,368,186 SH   SOLE   2,368,186 0 0
CELCUITY INC COM 15102K100   15,856,668 1,444,141 SH   SOLE   1,444,141 0 0
CELLDEX THERAPEUTICS INC NEW COM NEW 15117B202   21,432,393 631,665 SH   SOLE   631,665 0 0
COGENT BIOSCIENCES INC COM 19240Q201   65,901,748 5,566,026 SH   SOLE   5,566,026 0 0
CYMABAY THERAPEUTICS INC COM 23257D103   22,173,750 2,025,000 SH   SOLE   2,025,000 0 0
DAY ONE BIOPHARMACEUTICALS I COM 23954D109   8,831,552 739,661 SH   SOLE   739,661 0 0
DBV TECHNOLOGIES S A SPONSORED ADR 23306J101   176,105 92,687 SH   SOLE   92,687 0 0
ENLIVEN THERAPEUTICS INC COM 29337E102   47,928,232 2,348,272 SH   SOLE   2,348,272 0 0
IDEAYA BIOSCIENCES INC COM 45166A102   18,212,500 775,000 SH   SOLE   775,000 0 0
IMMUNOVANT INC COM 45258J102   17,073,000 900,000 SH   SOLE   900,000 0 0
KALVISTA PHARMACEUTICALS INC COM 483497103   2,812,977 312,553 SH   SOLE   312,553 0 0
KURA ONCOLOGY INC COM 50127T109   14,812,000 1,400,000 SH   SOLE   1,400,000 0 0
MERUS N V COM N5749R100   105,320,000 4,000,000 SH   SOLE   4,000,000 0 0
NUVALENT INC COM 670703107   48,495,500 1,150,000 SH   SOLE   1,150,000 0 0
SYNDAX PHARMACEUTICALS INC COM 87164F105   20,879,684 997,596 SH   SOLE   997,596 0 0
THIRD HARMONIC BIO INC COM 88427A107   4,777,744 993,294 SH   SOLE   993,294 0 0
VAXCYTE INC COM 92243G108   50,689,100 1,015,000 SH   SOLE   1,015,000 0 0
VERA THERAPEUTICS INC CL A 92337R101   87,472,500 5,450,000 SH   SOLE   5,450,000 0 0
VIRIDIAN THERAPEUTICS INC COM 92790C104   52,338,000 2,200,000 SH   SOLE   2,200,000 0 0
XENON PHARMACEUTICALS INC COM 98420N105   71,032,500 1,845,000 SH   SOLE   1,845,000 0 0